| 注册
首页|期刊导航|基础医学与临床|转酮醇酶在糖尿病及其并发症发生和治疗中作用的研究进展

转酮醇酶在糖尿病及其并发症发生和治疗中作用的研究进展

王泽颖 刘治 邰玉 杨忠彬 苏燕

基础医学与临床2024,Vol.44Issue(7):1023-1028,6.
基础医学与临床2024,Vol.44Issue(7):1023-1028,6.DOI:10.16352/j.issn.1001-6325.2024.07.1023

转酮醇酶在糖尿病及其并发症发生和治疗中作用的研究进展

Progress on the role of transketolase in occurrence and treatment of diabetes and its complications

王泽颖 1刘治 1邰玉 1杨忠彬 1苏燕1

作者信息

  • 1. 包头医学院 生物化学与分子生物学教研室,内蒙古 包头 014010
  • 折叠

摘要

Abstract

Transketolase(TKT)is an important enzyme that catalyzes the non-oxidative phase group transfer reac-tion of pentose phosphate pathway(PPP),and is involved in the metabolism of various energy substances in the body,such as glucose,ribose,nucleotides and lipids.TKT can reduce oxidative stress,inflammation,atheroscle-rosis,endothelial dysfunction and Tau protein phosphorylation by inhibiting advanced glycated end-produces(AGEs)produced by non-enzymatic glycosylation(NEG)of proteins and lipids in a high-glucose environment im-proving blood glucose,glucose tolerance and β cell function so to prevent and treat diabetes and its complications.This article reviews research progress on the mechanism of TKT in the treatment of diabetes mellitus and its compli-cations.

关键词

转酮醇酶/糖尿病/代谢/磷酸戊糖途径

Key words

transketolase/diabetes/metabolism/pentose phosphate pathway

分类

医药卫生

引用本文复制引用

王泽颖,刘治,邰玉,杨忠彬,苏燕..转酮醇酶在糖尿病及其并发症发生和治疗中作用的研究进展[J].基础医学与临床,2024,44(7):1023-1028,6.

基金项目

国家自然科学基金(81860029) (81860029)

内蒙古自然科学基金(2020MS08008) (2020MS08008)

草原英才滚动计划(2021) (2021)

2021 年卫生健康科技计划(202201394) (202201394)

基础医学与临床

OACSTPCD

1001-6325

访问量5
|
下载量0
段落导航相关论文